Pfizer's total revenue 2006-2018

Pfizer is a global pharmaceutical company and among the top pharmaceutical companies in the world. Pfizer is headquartered in New York City. As of 2018, their total revenue was about 53.7 billion U.S. dollars. Since 2006 the company’s revenue has remained relatively stable with some increase in 2010 and 2011. Their lowest revenue year was in 2008 when they generated just 47.5 billion U.S. dollars in revenue.

Pfizer’s global positioning

Pfizer’s products are available in over 125 countries worldwide and as of 2018 they have over 100 clinical research and development projects underway. Pfizer is the top pharmaceutical company based on global prescription drug sales and is among the top 5 pharmaceutical companies based on research and development (R&D) spending. Pfizer’s largest segment is Innovative Health (IH). The Innovative Health business focuses on various rare diseases, vaccines, immunology and internal medicine to name a few.

Pfizer’s top products

Pfizer has several products that are quite popular. In 2018, drugs in the Prevnar family, followed by Lyrica, were their top products based on revenue. However, Pfizer has several other drugs that are also well known. For example, Lipitor (atorvastatin calcium) is used in the treatment of high cholesterol. Over the years, however, Lipitor revenues have been on the decline, yet it remains part of Pfizer’s top products. One of Pfizer’s most well-known products, Viagra (sildenafil citrate), used in the treatment of erectile disfunction, has also been on the decline with 2018 having the lowest revenues on record. The low revenues are mainly attributable to Viagra’s loss of patent exclusivity in the U.S. in December 2017.

Pfizer's total revenue from 2006 to 2018

Revenue in millions of U.S. dollars
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Worldwide

Survey time period

2006 to 2018

Supplementary notes

This statistic was assembled from several editions of Pfizer's annual financial report.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pfizer"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.